Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone plus olopatadine versus mometasone in pediatric allergic rhinitis
IRCT20150426021944N5Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mometasone and olopatadine in allergic rhinitis (AR) (2 arms), sponsored by Urmia University of Medical Sciences. Started Jun 2024; status: completed.
02
Drugs
mometasoneolopatadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT20150426021944N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150426021944N5.